title: 5-Alpha reductase inhibitors and PSA screening for prostate cancer.
authors.affiliation: 1Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, and Sydney Medical School, University of Sydney, Sydney, NSW, Australia 2University of Otago, Wellington, New Zealand 3Melbourne Pathology and University of Melbourne, Melbourne, Vic, Australia.
authors.forename: Paul R
authors.initials: PR
authors.lastname: McKenzie
authors.forename: Brett
authors.initials: B
authors.lastname: Delahunt
authors.forename: James G
authors.initials: JG
authors.lastname: Kench
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Sikaris
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis*; D055088:Early Detection of Cancer; D006801:Humans; D007610:Kallikreins / Q000097:blood*; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis*
chemical_list: D007610:Kallikreins; D017430:Prostate-Specific Antigen